Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 19 (11), 83

Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment

Affiliations
Review

Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment

Laura G Cooney et al. Curr Psychiatry Rep.

Abstract

Purpose of review: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive age women and is associated with an increased prevalence of depression and anxiety symptoms. This review presents potential mechanisms for this increased risk and outlines treatment options.

Recent findings: Women with PCOS have increased odds of depressive symptoms (OR 3.78; 95% CI 3.03-4.72) and anxiety symptoms (OR 5.62; 95% CI 3.22-9.80). Obesity, insulin resistance, and elevated androgens may partly contribute to this association. Therefore, in addition to established treatment options, treatment of PCOS-related symptoms with lifestyle modification and/or oral contraceptive pills may be of benefit. Screening for anxiety and depression is recommended in women with PCOS at the time of diagnosis. The exact etiology for the increased risk in PCOS is still unclear. Moreover, there is a paucity of published data on the most effective behavioral, pharmacological, or physiological treatment options specifically in women with PCOS.

Keywords: Anxiety; Depression; PCOS; Treatment.

Similar articles

See all similar articles

Cited by 7 articles

See all "Cited by" articles

References

    1. Acta Med Iran. 2014;52(1):46-8 - PubMed
    1. J Int Med Res. 2008 Nov-Dec;36(6):1188-96 - PubMed
    1. Fertil Steril. 2017 May;107(5):1238-1245 - PubMed
    1. Fertil Steril. 2000 Apr;73(4):812-6 - PubMed
    1. Arch Gen Psychiatry. 2010 Mar;67(3):220-9 - PubMed

LinkOut - more resources

Feedback